Clinical trial

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT05673590

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-05-12

PhasePHASE3

Study timeline

Study start (actual)2023-05-12Date precision: day

Registry last updated2023-11-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Locally Advanced or Metastatic Non-Small Cell Lung Cancerunresolved

Interventions

Utidelone InjectionDRUG

Docetaxel InjectionDRUG · verified · RxNorm: docetaxel Injection

Sponsors & collaborators

Beijing Biostar Pharmaceuticals Co., Ltd.lead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05673590 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.